In a major setback to leading Indian vaccine manufacturer Bharat Biotech, the World Health Organization (WHO) has further delayed the emergency use authorisation (EUA) for its COVID-19 vaccine Covaxin. Media reports said quoting sources that the global health watchdog has sent more technical queries to its manufacturer Bharat Biotech.
In a major setback to leading Indian vaccine manufacturer Bharat Biotech, the World Health Organization (WHO) has further delayed the emergency use authorisation (EUA) for its COVID-19 vaccine Covaxin. Media reports said quoting sources that the global health watchdog has sent more technical queries to its manufacturer Bharat Biotech.